CITED2 and prostate carcinoma: Among genes uniquely downregulated by CBPD-409, we identified NKX3-1, CITED2 and CCND1, which are known for their critical roles in prostate cancer progression45–47 (Fig. 4f and Extended Data Fig. 7e).